埋め込み型生体材料の世界市場レポート 2024

埋め込み型生体材料の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.9%の年間複合成長率（CAGR）で2,179億8,000万米ドルに成長すると予想されます。予測される成長は、生体活性/生体吸収性材料、スマート/応答性生体材料、規制/安全基準、ハイブリッド複合材料、および組織工学の進歩に依存しています。予想される動向には、薬剤溶出インプラント、強化された生体適合性、3Dプリンティング/カスタマイズ、再生医療への焦点、およびナノテクノロジーの統合が含まれます。

ドレクセル大学による国立科学財団への20万米ドルの助成金などのプロジェクトへの割り当てからも明らかなように、新しい生体材料の進歩に対する政府機関の投資は、埋め込み型生体材料市場の成長の重要な原動力となっています。この財政的支援は、生体材料の血管新生に影響を与える、マクロファージの行動に対する生体材料を介した制御に関する調査を促進します。政府機関からの支援により、埋め込み型生体材料のさらなる進歩が促進される予定です。

心血管疾患の急増により、移植可能な生体材料市場の拡大が促進されると予想されます。心臓や血管に影響を与える症状を特徴とする心血管疾患は増加傾向にあり、埋め込み型生体材料に対する需要が高まっています。これらの材料は、心臓血管の問題に対処する上で極めて重要な役割を果たしており、損傷した組織を修復または置換するためのさまざまな医療機器や処置に採用されています。心血管疾患の有病率が高まるにつれ、患者の治療成績を向上させ、生活の質を向上させることを目的として、革新的な生体材料の必要性が最重要視されています。特に、2022年3月と2023年5月の統計は、英国と米国でそれぞれ心臓発作による死亡者数と心血管疾患の有病率を挙げて、この問題の深刻さを強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の埋め込み型生体材料市場、材料別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• メタリック
• セラミック
• ポリマー
• 天然
• 世界の埋め込み型生体材料市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 歯科
• 心臓血管
• 眼科
• 整形外科
• その他の用途
• 世界の埋め込み型生体材料市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 外来手術センター
• 専門クリニック

第7章 地域および国の分析

• 世界の埋め込み型生体材料市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の埋め込み型生体材料市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 埋め込み型生体材料市場の競合情勢
• 埋め込み型生体材料市場の企業プロファイル
  • BASF SE
  • 3M Company
  • Medtronic plc
  • Evonik Industries AG
  • Stryker Corporation

第31章 その他の大手および革新的な企業

• DuPont de Nemours Inc.
• Celanese Corporation
• Zimmer Biomet Holdings Inc.
• Biomet Inc.
• Koninklijke DSM NV
• Arthrex Inc.
• DePuy Synthes Companies
• Carpenter Technology Corporation
• Corbion NV
• GELITA AG
• Wright Medical Group NV
• CoorsTek Inc.
• CeramTec GmbH
• Orthofix Holdings Inc.
• Invibio Biomaterial Solutions plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Implantable biomaterials are natural or synthetic materials utilized in medical applications to support, enhance, or replace damaged tissues or biological structures.

These materials encompass metallic, ceramic, polymers, and natural substances. Metallic implants, often preferred in orthopedic prosthesis, enhance biological activities and are favored over polymeric and traditional ceramic biomaterials. They find applications in dental, cardiovascular, ophthalmology, orthopedic, and other medical fields, used across hospitals, ambulatory surgical centers, and specialty clinics.

The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with an implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable biomaterials market size has grown rapidly in recent years. It will grow from $127.97 billion in 2023 to $144.1 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth observed in the historic period can be attributed to several factors, including clinical success leading to positive patient outcomes, advancements in tissue engineering, development of surface modification techniques, achieving significant regulatory milestones, and the introduction of biodegradable materials in this field.

The implantable biomaterials market size is expected to see rapid growth in the next few years. It will grow to $217.98 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. Forecasted growth relies on bioactive/bioresorbable materials, smart/responsive biomaterials, regulatory/safety standards, hybrid composites, and tissue engineering advancements. Anticipated trends include drug-eluting implants, enhanced biocompatibility, 3D printing/customization, regenerative medicine focus, and nanotechnology integration.

Government organizations' investment in the advancement of new biomaterials, as evidenced by allocations to projects such as Drexel University's USD 200,000 grant to the National Science Foundation, is a significant driver of growth in the implantable biomaterials market. This financial support fosters research on biomaterial-mediated control over macrophage behavior, influencing biomaterial vascularization. The backing from government entities is poised to fuel further advancements in implantable biomaterials.

The surge in instances of cardiovascular diseases is anticipated to propel the expansion of the implantable biomaterial market. Characterized by conditions impacting the heart and blood vessels, cardiovascular diseases are on the rise, creating a heightened demand for implantable biomaterials. These materials play a pivotal role in addressing cardiovascular issues, employed in various medical devices and procedures to repair or replace damaged tissues. As the prevalence of cardiovascular problems increases, the necessity for innovative biomaterials becomes paramount, aiming to enhance patient outcomes and improve their quality of life. Notably, statistics from March 2022 and May 2023 underscore the magnitude of the issue, citing the number of deaths attributed to heart attacks and the prevalence of cardiovascular diseases in the UK and the United States, respectively.

The implantable biomaterials market faces substantial challenges due to limitations associated with biomaterial-based products. Notably, metal biomaterials can undergo corrosion within the body, triggered by chemical reactions such as enzymatic and acidic processes, potentially leading to metal ion toxicity. Similarly, polymer biomaterial implants exhibit intensive interaction with the body, resulting in wear and tear and the absorption of essential nutrients and water from the blood. Additionally, certain biomaterial implants may hinder bone ingrowth, experience loosening over time, or become dislodged, thereby restricting their utility and exerting a negative influence on the growth of the implantable biomaterials market.

Leading companies in the implantable biomaterial market are strategically directing their efforts towards the development of cutting-edge technology and products rooted in biomaterial technology, particularly for orthopaedic surgical applications. Biomaterial technology, a discipline encompassing the development, design, and application of materials interacting with biological systems, serves as a focal point for innovation. An exemplar is Acuitive Technologies Inc., a US-based medical device manufacturer, which introduced CITREGEN in September 2021. CITREGEN, a biomaterial technology, is utilized in musculoskeletal surgeries, enhancing outcomes for patients. This innovative device facilitates the attachment of soft tissue grafts to bone in reconstruction surgeries, featuring a distinctive design. CITREGEN's chemical and mechanical properties, including citrate, phosphate, and calcium, make it well-suited for orthopaedic surgical applications. Notably, CITRELOCK, an implantable device derived from CITREGEN, exhibits compressive strength comparable to cortical bone, maintaining structural integrity throughout the healing phase. This pioneering technology represents the first thermoset biodegradable synthetic polymer employed in implantable medical devices.

In April 2022, Integer Holdings Corporation, a U.S.-based medical device company, successfully acquired Connemara Biomedical Holdings Teoranta for an undisclosed sum. This strategic acquisition positions Integer to control implantable biomaterial technology, fostering its growth in the medical device industry. Connemara Biomedical Holdings Teoranta, based in Ireland, specializes in the manufacturing of biomaterials for cardiovascular implants.

Major companies operating in the implantable biomaterials market report are BASF SE; 3M Company; Medtronic plc; Evonik Industries AG; Stryker Corporation; DuPont de Nemours Inc.; Celanese Corporation; Zimmer Biomet Holdings Inc.; Biomet Inc.; Koninklijke DSM NV; Arthrex Inc.; DePuy Synthes Companies; Carpenter Technology Corporation; Corbion NV; GELITA AG; Wright Medical Group NV; CoorsTek Inc.; CeramTec GmbH; Orthofix Holdings Inc.; Invibio Biomaterial Solutions plc; Keystone Dental Inc.; KLS Martin SE & Co.; Collagen Matrix Inc.; Cam Bioceramics BV; Aap Implantate AG; Berkeley Advanced Biomaterials Inc.; AdvanSource Biomaterials Corporation; Collagen Solutions plc; Surgival SL; SBM France SAS

North America was the largest region in the implantable biomaterials market in 2023. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Biomaterials Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Material: Metallic; Ceramic; Polymers; Natural
• 2) By Application: Dental; Cardiovascular; Ophthalmology; Orthopedic; Other Applications
• 3) By End-user: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
• Companies Mentioned: BASF SE; 3M Company; Medtronic plc; Evonik Industries AG; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Biomaterials Market Characteristics

3. Implantable Biomaterials Market Trends And Strategies

4. Implantable Biomaterials Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Implantable Biomaterials Market Size and Growth

• 5.1. Global Implantable Biomaterials Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Implantable Biomaterials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Implantable Biomaterials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Implantable Biomaterials Market Segmentation

• 6.1. Global Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Metallic
• Ceramic
• Polymers
• Natural
• 6.2. Global Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Dental
• Cardiovascular
• Ophthalmology
• Orthopedic
• Other Applications
• 6.3. Global Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

7. Implantable Biomaterials Market Regional And Country Analysis

• 7.1. Global Implantable Biomaterials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Implantable Biomaterials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Implantable Biomaterials Market

• 8.1. Asia-Pacific Implantable Biomaterials Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Implantable Biomaterials Market

• 9.1. China Implantable Biomaterials Market Overview
• 9.2. China Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Implantable Biomaterials Market

• 10.1. India Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Implantable Biomaterials Market

• 11.1. Japan Implantable Biomaterials Market Overview
• 11.2. Japan Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Implantable Biomaterials Market

• 12.1. Australia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Implantable Biomaterials Market

• 13.1. Indonesia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Implantable Biomaterials Market

• 14.1. South Korea Implantable Biomaterials Market Overview
• 14.2. South Korea Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Implantable Biomaterials Market

• 15.1. Western Europe Implantable Biomaterials Market Overview
• 15.2. Western Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Implantable Biomaterials Market

• 16.1. UK Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Implantable Biomaterials Market

• 17.1. Germany Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Implantable Biomaterials Market

• 18.1. France Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Implantable Biomaterials Market

• 19.1. Italy Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Implantable Biomaterials Market

• 20.1. Spain Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Implantable Biomaterials Market

• 21.1. Eastern Europe Implantable Biomaterials Market Overview
• 21.2. Eastern Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Implantable Biomaterials Market

• 22.1. Russia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Implantable Biomaterials Market

• 23.1. North America Implantable Biomaterials Market Overview
• 23.2. North America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Implantable Biomaterials Market

• 24.1. USA Implantable Biomaterials Market Overview
• 24.2. USA Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Implantable Biomaterials Market

• 25.1. Canada Implantable Biomaterials Market Overview
• 25.2. Canada Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Implantable Biomaterials Market

• 26.1. South America Implantable Biomaterials Market Overview
• 26.2. South America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Implantable Biomaterials Market

• 27.1. Brazil Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Implantable Biomaterials Market

• 28.1. Middle East Implantable Biomaterials Market Overview
• 28.2. Middle East Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Implantable Biomaterials Market

• 29.1. Africa Implantable Biomaterials Market Overview
• 29.2. Africa Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Implantable Biomaterials Market Competitive Landscape And Company Profiles

• 30.1. Implantable Biomaterials Market Competitive Landscape
• 30.2. Implantable Biomaterials Market Company Profiles
  • 30.2.1. BASF SE
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. 3M Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medtronic plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Evonik Industries AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Stryker Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Implantable Biomaterials Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Celanese Corporation
• 31.3. Zimmer Biomet Holdings Inc.
• 31.4. Biomet Inc.
• 31.5. Koninklijke DSM NV
• 31.6. Arthrex Inc.
• 31.7. DePuy Synthes Companies
• 31.8. Carpenter Technology Corporation
• 31.9. Corbion NV
• 31.10. GELITA AG
• 31.11. Wright Medical Group NV
• 31.12. CoorsTek Inc.
• 31.13. CeramTec GmbH
• 31.14. Orthofix Holdings Inc.
• 31.15. Invibio Biomaterial Solutions plc

32. Global Implantable Biomaterials Market Competitive Benchmarking

33. Global Implantable Biomaterials Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Implantable Biomaterials Market

35. Implantable Biomaterials Market Future Outlook and Potential Analysis

• 35.1 Implantable Biomaterials Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Implantable Biomaterials Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Implantable Biomaterials Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer